Pacira Biosciences
PCRX
#5581
Rank
C$2.03 B
Marketcap
C$51.72
Share price
44.40%
Change (1 day)
57.61%
Change (1 year)
Categories

Market capitalization of Pacira Biosciences (PCRX)

Market cap: C$2.03 Billion

As of October 2026 Pacira Biosciences has a market cap of C$2.03 Billion. This makes Pacira Biosciences the world's 5581th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Pacira Biosciences from 2011 to 2026

End of year Market Cap

Year Marketcap Change
2026C$2.03 B24.76%
2025C$1.63 B25.29%
2024C$1.30 B-37.35%
2023C$2.07 B-13.55%
2022C$2.40 B-29.63%
2021C$3.41 B3.05%
2020C$3.31 B33.69%
2019C$2.47 B2.64%
2018C$2.41 B3.75%
2017C$2.32 B43.42%
2016C$1.62 B-58.64%
2015C$3.92 B5.53%
2014C$3.71 B80.69%
2013C$2.05 B263.22%
2012C$0.56 B273.85%
2011C$0.15 B

End of Day market cap according to different sources

On Oct 8th, 2026 the market cap of Pacira Biosciences was reported to be:

C$2.06 Billion
by Nasdaq info icon info icon
C$2.03 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Zogenix
ZGNX
C$2.13 B 4.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
C$0.17 B-91.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
C$1.96 B-3.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
C$0.65 B-67.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
C$96.66 M-95.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
C$11.52 M-99.43%๐Ÿ‡บ๐Ÿ‡ธ USA